San Diego, April 5-9, 2014, ChemPartner attended AACR.
The American Association for Cancer Research 2016 Annual Meeting，as one of the most important International tumor conference, was held in New Orleans on Apr 16th -20th .The topic was “Delivering Cures Through Cancer Science”.
It is reported that more than 6000 articles have been received, which contained the most advanced results of all cancer research areas. There were nearly 20,000 people joined the conference. The global famous researchers and scientists have presented several key developments focused on how to improve patients therapy covering protein transformation, DNA target repair, precision medicine and clinical trials. Among these, gene editing, CRISPR technology, epigenetic, stem cell and immunotherapy were the research hotspots. In addition, the Vice President of United States, Joe Biden also addressed the subject of “Moon Shoot” at the closing ceremony scene.
Throughout the conference, basic research, clinical transformation and early diagnosis were still the core theme. ChemPartner, as one of the exhibitors at Booth 240 overflowing with attendees, showed the outstanding research achievements in ADC, oncology, antibody discovery, and cell biology. The Business Development team based in US East Coast and West Coast, and the expertise teams of these four areas based in Shanghai attended this meeting.
As the leading enterprises in CRO industry, ChemPartner has competitive advantages in the field of tumor immunology, molecular biology etc. We will continue to make a contribution toward related biomedical research for cancer prevention and treatment.